What is Volpara Health?
Volpara Health is a clinically validated, AI-powered software designed to personalize screening and enable early detection of breast cancer. It’s not just another tech tool—it’s a game-changer in breast health, combining cutting-edge artificial intelligence with solid clinical science. The software integrates seamlessly into healthcare workflows, helping providers deliver smarter, more personalized care to patients. Focused on breast cancer prevention and early detection, Volpara Health is truly at the forefront of transforming how breast health is managed worldwide.
Main Benefits of Volpara Health
Volpara Health brings a ton of value to the table. Here are some key figures and facts that highlight its impact:
- Used by over 3,500 facilities, including top cancer screening centers across the US.
- More than 20 million women in 40 countries have had their breast density assessed using Volpara’s technology.
- Analyzed and deidentified over 130 million mammography and tomosynthesis images.
- Offers personalized breast cancer risk insights, including Tyrer-Cuzick modeling.
- Optimizes mammography quality and productivity for more efficient screening programs.
Personalized Breast Health Software
Volpara Health acts as a powerful ally in the fight against advanced-stage breast cancer. Its intelligent breast screening software is backed by rigorous science and designed to fit right into the way healthcare professionals work. The software personalizes detection strategies for each patient, making screening smarter and more effective. It’s all about catching cancer early and improving patient outcomes—because when it comes to breast health, timing is everything.
Clinical Decision Support for Informed Care
One of the standout features of Volpara Health is its clinical decision support system. It provides healthcare providers with solid clinical evidence to make informed care decisions. This means less guesswork and more confidence in screening results and patient management. By integrating risk models and real-time data, it supports clinicians in tailoring care plans that truly fit each patient’s unique risk profile.
Optimizing Screening Programs and Workflow
Efficiency matters, especially in busy screening centers. Volpara Health offers several products designed to streamline workflows and boost program performance:
- Patient Hub: Speeds up workflow with customizable patient reporting and communications.
- Scorecard: Provides essential patient risk insights for early detection.
- Risk Pathways: A comprehensive program for identifying, tracking, and managing high-risk patients.
- Analytics: Monitors team performance with automated image quality metrics.
- Live: Offers fast imaging feedback for on-the-job training.
- Quiver: Centralizes and automates compliance management.
Impact on Sustainable Development Goals (SDGs)
- SDG 3: Good Health and Well-being – Enhancing early cancer detection and improving patient outcomes.
- SDG 9: Industry, Innovation, and Infrastructure – Leveraging AI and advanced technology in healthcare.
- SDG 10: Reduced Inequalities – Making breast cancer screening accessible across 40 countries.
- SDG 17: Partnerships for the Goals – Collaborating with global healthcare providers and institutions.
Recent Developments and Industry Position
Volpara Health continues to push the boundaries of AI-driven cancer care. Recently, Lunit completed the acquisition of Volpara, marking a new chapter in pioneering next-level AI solutions for cancer detection. Volpara’s expertise is so respected that it literally wrote the eBook on AI in breast imaging—talk about leading the conversation! With a strong presence in New Zealand and beyond, Volpara is shaping the future of medical technology in breast health, combining science, innovation, and real-world impact.
